| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784565 | Taiwanese Journal of Obstetrics and Gynecology | 2017 | 4 Pages |
Abstract
Continuous oral cyclophosphamide can be used as an alternative salvage therapy in recurrent ovarian cancer with an acceptable response rate and toxicity. Additional clinical trials are required to evaluate its efficacy as maintenance therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chui-Na Wong, Chui-Nguk Wong, Fu-Shing Liu,